Bliss GVS Pharma informs about disclosure

12 Nov 2020 Evaluate

Bliss GVS Pharma has informed that the exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on November 11, 2020 for Gautam Rasiklal Ashra.

The above information is a part of company’s filings submitted to BSE.

Bliss GVS Pharma Share Price

103.85 -0.50 (-0.48%)
29-May-2024 10:09 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1473.45
Dr. Reddys Lab 5937.75
Cipla 1480.20
Zydus Lifesciences 1039.90
Lupin 1604.80
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.